Wide range applications of botulinum toxin in medicine - literature review
DOI:
https://doi.org/10.12775/JEHS.2023.45.01.014Keywords
Botulinum toxin, treatment, botulismAbstract
Introduction and purpose :
Botulinum toxin is one of the most dangerous natural toxins. Botulinum toxin poisoning causes botulism. Botulism is a set of systemic symptoms resulting from flaccid muscle paralysis. The first symptomatology of toxin poisoning was described at the beginning of the 19th century. After more than 200 years, botulinum toxin is associated primarily with aesthetic medicine treatments, where it is used to temporarily improve the appearance, mainly by reducing mimic wrinkles.
Aim of the study:
The aim of the study is to collect information available in PubMed, Google Scholar, academic textbooks and characteristics of botulinum toxin medicinal products, especially regarding its wide use, mechanism of action, adverse events and contraindications. As a result, the presentation of the versatile use of botulinum toxin as a medicinal product in many fields of medicine.
Brief description of the state of knowledge:
Botulinum toxin is produced by the anaerobic bacteria Clostridium botulinum. Its mechanism of action consists in flaccid muscle paralysis. Most preparations with botulinum toxin are only registered for strictly defined aesthetic medicine treatments. Other registered indications for the use of medicinal products with botulinum toxin include overactive bladder, various types of spasticity and prevention of headaches. In addition, in medicine, botulinum toxin is commonly used off-label.
Summary:
Botulinum toxin is widely used not only in aesthetic medicine. Intramuscular injections of botulinum toxin are successfully used in various fields of medicine, such as: urology, neurology, ophthalmology, gastroenterology, dermatology, gynecology, otolaryngology, dentistry and even psychiatry.
References
Zbrojkiewicz, M., Lebiedowska, A., & Błońska-Fajfrowska, B. B. F. B. (2018). Toksyna botulinowa w medycynie i kosmetologii–dwustuletnia historia i nowe perspektywy. Postępy Higieny i Medycyny Doświadczalnej, 72, 278-289.
Choudhury S, Baker MR, Chatterjee S, Kumar H. Botulinum Toxin: An Update on Pharmacology and Newer Products in Development. Toxins (Basel). 2021 Jan 14;13(1):58. doi: 10.3390/toxins13010058. PMID: 33466571; PMCID: PMC7828686.
Patrick R. Murray, Michael A. Pfaller, Ken S. Rosenthal, Mikrobiologia wyd. Edra Urban & Partner, 2016, 373-374.
Heczko PB, Pietrzyk A, Wróblewska M. Mikrobiologia lekarska Warszawa 2016, wyd. PZWL. 133-134.
Szczeklik A., Interna Szczeklika., wyd. Medycyna Praktyczna, 2020. „Zatrucie toksyną botulinową (botulizm, zatrucie jadem kiełbasianym)”, 2460-2461
Dressler, D., & Adib Saberi, F. (2005). Botulinum toxin: mechanisms of action. European neurology, 53(1), 3-9.
Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev. 2000 Apr;80(2):717-66. doi: 10.1152/physrev.2000.80.2.717. PMID: 10747206.
Muthane UB. Botulinum toxin: pharmacology and its current therapeutic evidence for use. Neurologica; 2/2006.
American Academy of Neurology Assesment. The clinical usefulness of botulinum toxin A in treating neurologic disorders. Neurology 1990; 40: 1332-1336.
Wolska, O., Kiebzak, W., Tomaszewski, W., Kowalski, I. M., Majewski, M., Szarek, J., & Zaborowska-Sapeta, K. (2008). Zastosowanie toksyny botulinowej w praktyce klinicznej.
Gąsowski, M., Guzik-Makaruk, E. M., & Kuligowska, A. (2022). Wybrane aspekty stosowania toksyny botulinowej z perspektywy prawa karnego i kryminologii. Studia Prawnoustrojowe, (56).
Charakterystyka Produktu Leczniczego BOTOX firmy Allergan. Dostępne online:
https://rejestrymedyczne.ezdrowie.gov.pl/api/rpl/medicinal-products/26784/characteristic (dostęp 13.06.2023r.)
Charakterystyka Produktu Leczniczego Letybo. Dostępne online:
https://rejestrymedyczne.ezdrowie.gov.pl/api/rpl/medicinal-products/43731/characteristic (dostęp 13.06.2023r.)
Charakterystyka Produktu Leczniczego Alluzience. Dostępne online: https://rejestrymedyczne.ezdrowie.gov.pl/api/rpl/medicinal-products/42946/characteristic (dostęp 13.06.2023r.)
Charakterystyka Produktu Leczniczego Bocuture. Dostępne online: https://rejestrymedyczne.ezdrowie.gov.pl/api/rpl/medicinal-products/23816/characteristic (dostęp 13.06.2023r.)
Mostafa D.: A successful management of sever gummy smile using gingivectomy and botulinum toxin injection: A case report. Int J Surg Case Rep. 2018;42:169-174. doi: 10.1016/j.ijscr.2017.11.055. Epub 2017 Dec 1.
Przybylska, P., Morawska, A., Ortarzewska, M., & Parvanov, M. (2021). The use of botulinum toxin injection into the mentalis muscle in aesthetic medicine procedures. Journal of Face Aesthetics, 4(1), 58-64.
Siastała, P. "Metody rewitalizacji okolic oczu toksyną botulinową z punktu widzenia lekarza okulisty.” Kosmetologia Estetyczna 1/2019/vol.8: 111-114.
Drożdżyńska, M., Sobieraj-Garbiak, I., Chlasta, A., & Jastrzębska, M. (2015). Toksyna botulinowa i jej zastosowanie w medycynie. Diagn. Lab, 51, 139-146.
Wheeler, A., & Smith, H. S. (2013). Botulinum toxins: mechanisms of action, antinociception and clinical applications. Toxicology, 306, 124-146.
Herd, C. P., Tomlinson, C. L., Rick, C., Scotton, W. J., Edwards, J., Ives, N., ... & Sinclair, A. (2018). Botulinum toxins for the prevention of migraine in adults. Cochrane Database of Systematic Reviews, (6).
Becker WJ. Botulinum Toxin in the Treatment of Headache. Toxins (Basel). 2020 Dec 17;12(12):803. doi: 10.3390/toxins12120803. PMID: 33348571; PMCID: PMC7766412.
Kuo HC. Botulinum Toxin Brings a Light to the Shadow of Functional Urology. Toxins (Basel). 2023 May 6;15(5):321. doi: 10.3390/toxins15050321. PMID: 37235356; PMCID: PMC10222981.
Grzybowski A. Okulistyka, Edra Urban & Partner, 2020: 285.
Dołomisiewicz, D., Lipiec, M., Mielniczek, K., & Rzepakowska, A. (2022). Toksyna botulinowa–przegląd zastosowań w otorynolaryngologii. Polski Przegląd Otorynolaryngologiczny, 11(3), 30-38.
Rohrbach S, Junghans K, Köhler S, Laskawi R. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. Head Face Med. 2009 Oct 16;5:18. doi: 10.1186/1746-160X-5-18. PMID: 19835591; PMCID: PMC2770996.
Albanese A, Bentivoglio AR, Cassetta E, Viggiano A, Maria G, Gui D. Review article: the use of botulinum toxin in the alimentary tract. Aliment Pharmacol Ther. 1995 Dec;9(6):599-604. doi: 10.1111/j.1365-2036.1995.tb00428.x. PMID: 8824646.
Bielecki, K. (2006). Anal fissure. Postępy Nauk Medycznych.
Piech, P., Sudzińska, H., Pietrak, J., Kozioł, M., Maślanko, M., Wilczyńska, K., ... & Łuczyk, R. (2017). Botulinum toxin in bruxism treatment. Journal of Education, Health and Sport, 7(7), 398-411.
Schlaeger JM, Glayzer JE, Villegas-Downs M, Li H, Glayzer EJ, He Y, Takayama M, Yajima H, Takakura N, Kobak WH, McFarlin BL. Evaluation and Treatment of Vulvodynia: State of the Science. J Midwifery Womens Health. 2023 Jan;68(1):9-34. doi: 10.1111/jmwh.13456. Epub 2022 Dec 19. PMID: 36533637; PMCID: PMC10107324.
Spruijt MA, Klerkx WM, Kelder JC, Kluivers KB, Kerkhof MH. The efficacy of botulinum toxin a injections in pelvic floor muscles in chronic pelvic pain patients: a systematic review and meta-analysis. Int Urogynecol J. 2022 Nov;33(11):2951-2961. doi: 10.1007/s00192-022-05115-7. Epub 2022 Apr 1. PMID: 35362767; PMCID: PMC9569307.
Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ. Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. Clin Cosmet Investig Dermatol. 2023 May 31;16:1387-1406. doi: 10.2147/CCID.S385861. PMID: 37284568; PMCID: PMC10239632.
Campanati, A., Martina, E., Giuliodori, K., Consales, V., Bobyr, I., & Offidani, A. (2017). Botulinum toxin off-label use in dermatology: a review. Skin appendage disorders, 3(1), 39-56.
Finzi E. Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry. Toxins (Basel). 2023 May 14;15(5):336. doi: 10.3390/toxins15050336. PMID: 37235370; PMCID: PMC10224294.
Kozubski W, Liberski P, Neurologia, wyd. PZWL, wyd. II, tom 2, 322.
Small R. Botulinum toxin injection for facial wrinkles. Am Fam Physician. 2014 Aug 1;90(3):168-75. PMID: 25077722.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Aleksandra Serwik-Trandasir, Agata Kania, Malwina Gonet, Karolina Miszczyk, Karolina Włodarczyk-Cybulska, Patrycja Maj, Natalia Sergiel, Piotr Mozer, Jakub Maternia, Michal Lazar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 440
Number of citations: 0